ST Germain D J Co. Inc. Boosts Stake in The Procter & Gamble Company (NYSE:PG)

ST Germain D J Co. Inc. raised its holdings in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 6.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 206,896 shares of the company’s stock after buying an additional 11,730 shares during the period. Procter & Gamble comprises approximately 1.6% of ST Germain D J Co. Inc.’s investment portfolio, making the stock its 11th biggest position. ST Germain D J Co. Inc.’s holdings in Procter & Gamble were worth $34,686,000 at the end of the most recent quarter.

Other hedge funds have also recently modified their holdings of the company. Geode Capital Management LLC boosted its stake in shares of Procter & Gamble by 7.0% during the third quarter. Geode Capital Management LLC now owns 55,204,776 shares of the company’s stock valued at $9,538,327,000 after purchasing an additional 3,619,466 shares in the last quarter. FMR LLC grew its stake in Procter & Gamble by 2.7% in the third quarter. FMR LLC now owns 26,556,319 shares of the company’s stock valued at $4,599,554,000 after purchasing an additional 689,282 shares during the last quarter. Legal & General Group Plc raised its holdings in Procter & Gamble by 0.6% in the second quarter. Legal & General Group Plc now owns 21,632,054 shares of the company’s stock worth $3,567,556,000 after purchasing an additional 122,190 shares in the last quarter. Franklin Resources Inc. boosted its holdings in shares of Procter & Gamble by 10.2% in the 3rd quarter. Franklin Resources Inc. now owns 18,988,721 shares of the company’s stock valued at $3,290,573,000 after buying an additional 1,760,214 shares in the last quarter. Finally, Fisher Asset Management LLC grew its position in shares of Procter & Gamble by 4.7% in the 3rd quarter. Fisher Asset Management LLC now owns 18,380,610 shares of the company’s stock worth $3,183,522,000 after buying an additional 830,476 shares during the last quarter. Institutional investors own 65.77% of the company’s stock.

Insider Buying and Selling

In related news, CEO Gary A. Coombe sold 47,847 shares of the firm’s stock in a transaction dated Wednesday, November 27th. The stock was sold at an average price of $179.84, for a total transaction of $8,604,804.48. Following the completion of the transaction, the chief executive officer now directly owns 39,977 shares in the company, valued at $7,189,463.68. This trade represents a 54.48 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO R. Alexandra Keith sold 1,992 shares of the business’s stock in a transaction dated Tuesday, October 22nd. The stock was sold at an average price of $170.00, for a total transaction of $338,640.00. Following the sale, the chief executive officer now owns 13,783 shares in the company, valued at $2,343,110. This trade represents a 12.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 75,439 shares of company stock worth $13,317,460. Company insiders own 0.18% of the company’s stock.

Analyst Ratings Changes

Several analysts recently commented on the stock. Hsbc Global Res upgraded shares of Procter & Gamble to a “strong-buy” rating in a research report on Friday, October 4th. Piper Sandler initiated coverage on Procter & Gamble in a report on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 price target for the company. Evercore ISI raised their price objective on Procter & Gamble from $180.00 to $183.00 and gave the company an “outperform” rating in a report on Monday, October 21st. Barclays downgraded Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 target price for the company. in a research note on Monday, September 30th. Finally, DA Davidson reissued a “buy” rating and issued a $209.00 price target on shares of Procter & Gamble in a research note on Friday, December 27th. Eight equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, Procter & Gamble has an average rating of “Moderate Buy” and a consensus price target of $179.75.

Read Our Latest Analysis on Procter & Gamble

Procter & Gamble Trading Down 1.8 %

Shares of PG traded down $2.91 during midday trading on Friday, reaching $159.19. The company had a trading volume of 2,531,893 shares, compared to its average volume of 5,868,981. The Procter & Gamble Company has a 1-year low of $146.28 and a 1-year high of $180.43. The company has a quick ratio of 0.55, a current ratio of 0.75 and a debt-to-equity ratio of 0.50. The firm has a 50 day simple moving average of $169.77 and a 200-day simple moving average of $169.64. The stock has a market cap of $374.90 billion, a PE ratio of 27.45, a price-to-earnings-growth ratio of 3.70 and a beta of 0.45.

Procter & Gamble (NYSE:PGGet Free Report) last released its quarterly earnings data on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.90 by $0.03. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The firm had revenue of $21.74 billion during the quarter, compared to analysts’ expectations of $21.99 billion. During the same period last year, the business earned $1.83 earnings per share. Procter & Gamble’s revenue was down .6% compared to the same quarter last year. Research analysts forecast that The Procter & Gamble Company will post 6.94 EPS for the current fiscal year.

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Recommended Stories

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.